Skip to content
Bills from the 2019–20 session

Assembly Bill 542

Allowing reimbursement of certain expenses for patients participating in cancer clinical trials

Stopped before the full Assembly voted

The recommended passing it, but the full Assembly never voted on it. To try again, a lawmaker would have to start a new bill.

  1. Introduced, passed

    Oct 14, 2019

  2. Committee, passed

    Approved

  3. Assembly vote, stopped here

    Stopped here. The full Assembly never voted on it.

  4. Senate vote, not reached

  5. Governor, not reached

  6. Law, not reached

Latest entry in the official record, Apr 1, 2020: “Failed to pass pursuant to ⁠”

Read the bill

Following saves it on this device. New actions show on your Following page. You can also get updates in a feed reader.

What it would have done

Summary by the , the Legislature's nonpartisan drafting office. It's their wording, not ours.

This bill provides that reimbursement of certain patient-incurred expenses related to participation in a cancer clinical trial will not be considered undue inducement to participate in a cancer clinical trial. Under the bill, reimbursement of travel, ancillary costs, and other direct patient-incurred expenses related to cancer clinical trial participation will not be considered an undue inducement to participate in a cancer clinical trial, and reimbursement for travel and ancillary costs may not be considered coercive or as exerting undue influence to participate in a cancer clinical trial, but rather as a means to create parity in cancer clinical trial access and remove a barrier to participation. The bill requires all sponsors of cancer clinical trials to provide, during the informed consent process, potential participants with information relating to the possible availability of reimbursement for certain expenses. Under the bill, language informing patient-subjects that reimbursement entities or programs that cover travel, ancillary costs, and other direct patient-incurred expenses may be available must be submitted for review to the relevant federally designated institutional review board in conjunction with the review of a proposed cancer clinical trial and included in the informed consent form approved by the institutional review board. The reimbursement entity or program must also disclose the nature of the ancillary support and general guidelines on financial eligibility to interested patient-subjects and employ a reimbursement process that conforms to federal law and guidance.

Who's behind it

19 lawmakers are its ⁠. 16 are Republicans and 3 are Democrats.

11 more lawmakers ⁠.

See all 30 names

Authors (19)

Signed on in support (11)

How lawmakers voted

There was one vote on this bill.

Assembly Committee on Health vote to recommend it

Passed, 15 to 0 · Feb 4, 2020

No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.

Official motion: “Report passage recommended by Committee on Health, Ayes 15, Noes 0”. Official record · This vote on its own page

What happened

  1. Apr 1, 2020

    The session ended, and the bill died with it.

  2. Feb 4, 2020

    Sent to the Assembly Committee on Rules.

  3. Feb 4, 2020

    The committee voted to recommend passing it, 15 to 0.

  4. Jan 7, 2020

    The committee held a public hearing.

  5. Oct 18, 2019 to Nov 20, 2019

    2 more representatives signed on in support.

  6. Oct 14, 2019

    Sent to the Assembly Committee on Health.

  7. Oct 14, 2019

    Introduced in the Assembly.

See the official record, word for word
  1. Oct 14, 2019 · Assembly

    Introduced by Representatives Kulp, Duchow, Rodriguez, Dittrich, Sinicki, Skowronski, Tittl, Steffen, Spiros, Ott, Mursau, Knodl, Kerkman, Horlacher, Felzkowski, Ballweg, Anderson, Allen and C. Taylor; cosponsored by Senators Kooyenga, Darling, Carpenter, Erpenbach, Jacque, L. Taylor, Smith, Olsen and Craig

  2. Oct 14, 2019 · Assembly

    Read first time and referred to Committee on Health

  3. Oct 18, 2019 · Assembly

    Representative Subeck added as a coauthor

  4. Nov 20, 2019 · Assembly

    Representative Snyder added as a coauthor

  5. Jan 7, 2020 · Assembly

    Public hearing held

  6. Jan 29, 2020 · Assembly

    Executive action taken

  7. Feb 4, 2020 · Assembly

    Report passage recommended by Committee on Health, Ayes 15, Noes 0

  8. Feb 4, 2020 · Assembly

    Referred to committee on Rules

  9. Apr 1, 2020 · Assembly

    Failed to pass pursuant to Senate Joint Resolution 1

Terms on this page

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

More in the glossary

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1. More in the glossary

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis. More in the glossary

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor. More in the glossary

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor. More in the glossary

Roll call

A vote where each lawmaker's yes or no is recorded by name.

Official term: Roll call vote. More in the glossary

From the Wisconsin Legislature's official record, checked Sep 15, 2026. See the source

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor

Roll call

A vote where each lawmaker's yes or no is recorded by name.

Official term: Roll call vote